Chromosomal abnormalities in human glioblastomas: Gain in chromosome 7p correlating with loss in chromosome 10q

Molecular Carcinogenesis

Volumn 36, Issue 1, 2003, Pages 6-14

  Del Mar Inda, María ^a   Fan, Xing ^a   Muñoz, Jorge ^a   Perot, Christine ^b   Fauvet, Didier ^b   Danglot, Giselle ^b   Palacio, Ana ^c   Madero, Pilar ^c   Zazpe, Idoya ^d   Portillo, Eduardo ^d   Tuñón, Teresa ^d   Martínez Peñuela, José María ^d   Alfaro, Jorge ^e   Eiras, José ^e   Bernheim, Alain ^b   Castresana, Javier S ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Ctro Analisis Geneticos Citogen   (Spain)

^d Universidad Pública de Navarra   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Comparative genomic hybridization; Cyclin dependent kinase inhibitor 2A; Deleted in malignant brain tumors 1; Epidermal growth factor receptor; Phosphatase and tensin homologue deleted in chromosome 10

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; PHOSPHATASE;

ARTICLE; CHROMOSOME 10Q; CHROMOSOME 7P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE LOCUS; GENE MAPPING; GENETIC GAIN; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MARKER GENE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

EID: 0037225898     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10085     Document Type: Article

References (27)

1. Davies MP, Gibbs FE, Halliwell N, et al. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. Br J Cancer 1999;79:1542-1548.
2. Fan X, Furnari FB, Cavenee WK, Castresana JS. Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells. Int J Oncol 2001;18:1023-1026.
3. Fan X, Gomez L, Nistal M, Sierrasesumaga L, Castresana JS. Differential polymerase chain reaction: A technical comparison of three methods for the detection of CDK4 gene amplification in glioblastomas. Int J Oncol 1998;13:963-966.
4. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 1987;84:6899-6903.
5. Karlbom AE, James CD, Boethius J, et al. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 1993;92:169-174.
6. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-721.
7. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995;55:20-23.
8. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 1997;57:5254-5257.
9. Tohma Y, Gratas C, Biernat W, et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 1998;57:684-689.
10. Mao X, Hamoudi RA. Molecular and cytogenetic analysis of glioblastoma multiforme. Cancer Genet Cytogenet 2000; 122:87-92.
11. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 1995; 60:812-819.
12. Jung V, Romeike BF, Henn W, et al. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 1999;58:993-999.
13. Nishizaki T, Ozaki S, Harada K, et al. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosom Cancer 1998;21:340-346.
14. Fan X, Paetau A, Aalto Y, et al. Gain of chromosome 3 and loss of 13q are frequent alterations in pituitary adenomas. Cancer Genet Cytogenet 2001;128:97-103.
15. Fan X, Muñoz J, Sanko SG, Castresana JS. PTEN, DMBT1 and p16 alterations in diffusely infiltrating astrocytomas. Int J Oncol 2002;21:667-674.
16. Fan X, Gomez L, Nistal M, Sierrasesumaga L, Castresana JS. Lack of gene amplification as a mechanism of CDK4 activation in human neuroblastoma. Oncol Rep 1999;6: 647-650.
17. Fan X, Inda MM, Tuñón T, Castresana JS. Improvement of the methylation specific PCR technical conditions for the detection of p16 promoter hypermethylation in small amounts of tumor DNA. Oncol Rep 2002;9:181-183.
18. Knuutila S, Björkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies. Am J Pathol 1998;152:1107-1123.
19. Mottolese M, Natali PG, Coli A, et al. Comparative analysis of proliferating cell nuclear antigen and epidermal growth factor receptor expression in glial tumours: Correlation with histological grading. Anticancer Res 1998;18:1951-1956.
20. Dirks PB, Rutka JT. Current concepts in neuro-oncology: The cell cycle: A review. Neurosurgery 1997;40:1000-1013.
21. Galanis E, Buckner J, Kimmel D, et al. Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. Int J Oncol 1998;13:717-724.
22. Mohapatra G, Bollen AW, Kim DH, et al. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosom Cancer 1998;21:195-206.
23. Wang Y, Hagel C, Hamel W, Muller S, Kluwe L, Westphal M. Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol 1998;96:357-364.
24. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-1947.
25. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 1997;15:356-362.
26. Mollenhauer J, Wiemann S, Scheurlen W, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997;17:32-39.
27. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.